Press Releases
Alkermes Announces Positive Results from Clinical Study of ALKS...
Alkermes, Inc. (NASDAQ: ALKS) today announced positive topline results from a phase 1b, double-blind, randomized, placebo-controlled study of ALKS 9070 in patients with schizophrenia. ...
Press Releases
Provence Technologies and NexGenix announce successful lead compound development
Provence Technologies, a service provider in fine organic chemistry, and NexGenix Pharmaceuticals, a discovery and development company focused on the "next generation" of targeted therapies...
Press Releases
Adocia launches Phase IIa clinical study on type 1...
Adocia SAS, a privately-held biotechnology company specialized in regenerative medicine and in the treatment of chronic diseases, announced today the launch of its second...
Press Releases
PupPharma moves into the Biocitech science park
Biocitech, the Paris life sciences technology park, announces the arrival of a new resident, PupPharma, which becomes the 27th company to set up shop there....
Press Releases
Exclusive NHS Free podcast; Value Based Pricing: Do you...
Omar Ali is the Formulary Development Pharmacist for Surrey & Sussex Healthcare NHS Trust and also sits on the External reference Group for Cost Impact...
Press Releases
Integromics announces winners of proteomics grant competition
Integromics, a market leader in IT solutions for life sciences in the field of genomics and proteomics, today announces the two winners of the Integromics...
Press Releases
Launch of new CiToxLAB group
CiToxLAB announcement of the new name and logo for the company. The newly established group, created through the merger of CIT and LAB Research, provides...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.